Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Avalyn Pharma (NASDAQ:AVLN) Stock Among Today's Most Active: Second Quarter 2026 Results, IPO Proceeds and Clinical Trial Timelines

Avalyn Pharma Inc. (NASDAQ:AVLN) shares were trading at USD 24.83 on October 28, 2026, down 3.87%, with a relative volume at time of 3.70. The clinical-stage company completed its initial public offering on May 1, 2026 and filed its quarterly report for the period …

Nitish Kishor | 28 October 2026

Avantor (NYSE:AVTR) Stock Sees Unusual Volume: Third Quarter 2026 Results, Updated Full-Year Guidance and Goodwill Risk Disclosure

Avantor, Inc. (NYSE:AVTR) shares were trading at USD 16.65 on October 28, 2026, down 2.83%, with a relative volume at time of 3.92. The company, which reports through two segments, filed its Form 10-Q for the quarter ended September 30, 2026 on October 28, …

Nitish Kishor | 28 October 2026

Axogen (NASDAQ:AXGN) Stock Among Today's Most Active: Third Quarter 2026 Results, BioCircuit Acquisition and Raised Revenue Guidance

Axogen, Inc. (NASDAQ:AXGN) shares were trading at USD 48.38 on October 28, 2026, up 29.14%, with a relative volume at time of 15.19. The peripheral nerve repair company completed its BioCircuit acquisition on October 1 and reported third quarter 2026 results with raised full-year …

Nitish Kishor | 28 October 2026

Bausch + Lomb (NYSE:BLCO) Stock at 7.74 Relative Volume: Third Quarter 2026 Results, Raised Guidance and Pipeline Updates

Bausch + Lomb Corporation (NYSE:BLCO) shares were trading at USD 19.56 on October 28, 2026, up 11.01%, with a relative volume at time of 7.74. The eye health company reported third-quarter 2026 results on October 28 and updated its full-year 2026 revenue and adjusted …

Nitish Kishor | 28 October 2026

Beam Therapeutics (NASDAQ:BEAM) Stock in the Volume Spotlight: Second Quarter 2026 Results, Risto-cel BLA Plans and Credit Facility

Beam Therapeutics Inc. (NASDAQ:BEAM) shares were trading at USD 28.30 on October 28, 2026, up 13.65%, with a relative volume at time of 4.21. The gene editing company dosed the first patient in a BEAM-302 pivotal cohort in July 2026 and filed its quarterly …

Nitish Kishor | 28 October 2026

Boston Scientific (NYSE:BSX) Stock In Play Today: Third Quarter 2026 Results, Cybersecurity Incident and Updated Guidance

Boston Scientific (NYSE:BSX) shares were trading at USD 43.50 on October 28, 2026, down 3.47%, with a relative volume at time of 5.92. The medical technology company reported third quarter 2026 results on October 28, 2026, along with updated full-year and fourth quarter guidance …

Nitish Kishor | 28 October 2026

Chemed (NYSE:CHE) Stock in the Volume Spotlight: Third Quarter 2026 Results, Roto-Rooter Franchise Acquisition and Updated Guidance

Chemed Corporation (NYSE:CHE) shares were trading at USD 547.66 on October 28, 2026, up 7.58%, with a relative volume at time of 3.02. The company, which operates VITAS Healthcare and Roto-Rooter, re-acquired California franchise territories during the third quarter and reported third quarter 2026 …

Nitish Kishor | 28 October 2026

Ensign Group (NASDAQ:ENSG) Stock Among Today's Most Active: Third Quarter 2026 Results, Credit Facility Amendment and Share Repurchases

The Ensign Group (NASDAQ:ENSG) shares were trading at USD 184.63 on October 28, 2026, up 8.92%, with a relative volume at time of 4.51. The post-acute care provider amended its Credit Facility on August 19, 2026, and filed its Form 10-Q for the third …

Nitish Kishor | 28 October 2026

GE HealthCare (NASDAQ:GEHC) Stock In Play Today: Third Quarter 2026 Results, SOFIE Biosciences Acquisition and Raised 2026 Outlook

GE HealthCare Technologies (NASDAQ:GEHC) shares were trading at USD 76.85 on October 28, 2026, up 8.06%, with a relative volume at time of 3.65. The healthcare solutions provider announced an agreement to acquire SOFIE Biosciences on October 5, 2026, and reported third quarter 2026 …

Nitish Kishor | 28 October 2026

Generate Biomedicines (NASDAQ:GENB) Stock Sees Unusual Volume: Second Quarter 2026 Results, Pivotal Asthma Trials and Cash Runway

Generate Biomedicines (NASDAQ:GENB) shares were trading at USD 15.00 on October 28, 2026, up 13.55%, with a relative volume at time of 6.52. The clinical-stage company closed its initial public offering on March 2, 2026, and filed its quarterly report on Form 10-Q for …

Nitish Kishor | 28 October 2026
Support

Hi! How can we help you today?

Loading…